TNFSF11 and rheumatoid arthritis: Therefore, RANKL provides an interesting candidate for resolution of inflammatory resorption in RA, whereas a dual inhibition of RANKL and TNF seems a promising therapeutic approach for severe inflammatory osteolytic arthritis.